ClinicalThought


Share

Program Content

Activities

  • FAQs: Role of BTKis in MCL
    FAQs: Current and Emerging Roles of BTK Inhibitors in MCL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 19, 2023

    Expires: October 18, 2024

Faculty

cover img faculity

Brad Kahl, MD

Professor of Medicine
Washington University in St Louis
Director, Lymphoma Program
Siteman Cancer Center
St Louis, Missouri

cover img faculity

Julie M Vose, MD, MBA

Payne Presidential Chair
Chief, Division of Hematology/Oncology
University of Nebraska Medical Center
Buffett Cancer Center
Omaha, Nebraska

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Lilly, and Merck Sharp & Dohme LLC.

AstraZeneca

Lilly

Merck Sharp & Dohme, LLC

Partners

Clinical Care Options, LLC

ProCE Banner